Detalles de la búsqueda
1.
Impact of hydrolysis-mediated clearance on the pharmacokinetics of novel anaplastic lymphoma kinase inhibitors.
Drug Metab Dispos
; 41(1): 238-47, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23118327
2.
Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent Cancers.
J Med Chem
; 66(23): 15629-15647, 2023 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37967851
3.
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors.
Cell Chem Biol
; 28(2): 134-147.e14, 2021 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33086052
4.
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. 1993.
J Immunol
; 188(7): 2936-47, 2012 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22442491
5.
The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer.
J Med Chem
; 55(14): 6523-40, 2012 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-22734674
Resultados
1 -
5
de 5
1
Próxima >
>>